迟发型3-羟基-3-甲基戊二酸尿症导致脑白质病

马艳艳; 宋金青; 吴桐菲; 刘玉鹏; 肖江喜; 姜玉武; 杨艳玲

PDF(1029 KB)

中国当代儿科杂志 ›› 2011, Vol. 13 ›› Issue (5) : 392-395.

疑难病研究

迟发型3-羟基-3-甲基戊二酸尿症导致脑白质病

马艳艳，宋金青，吴桐菲，刘玉鹏，肖江喜，姜玉武，杨艳玲

作者信息 +

Leucodystrophy induced by late onset 3-hydroxy-3-methylglutaric aciduria

MA Yan-Yan, SONG Jin-Qing, WU Tong-Fei, LIU Yu-Peng, XIAO Jiang-Xi, JIANG Yu-Wu, YANG Yan-Ling

Author information +

文章历史 +

摘要

3-羟基-3-甲基戊二酸尿症是一种罕见的有机酸代谢病，病因为常染色体隐性遗传所导致的3-羟基-3-甲基戊二酰辅酶A裂解酶缺陷。患者通常在新生儿期至婴幼儿期发病。本研究报告1例晚发型3-羟基3-甲基戊二酸尿症导致的脑白质病。患儿为7岁男孩，急性起病，表现为头痛、困倦、呕吐, 进行性加重，一般化验发现肝损害、酮症、白细胞减少，脑磁共振扫描示双侧脑白质对称弥漫性病变。血液羟异戊酰肉碱、乙酰肉碱显著增高。尿液3-羟基-3-甲基戊二酸显著增高，3-甲基戊烯二酸、3-羟基戊二酸、甲基巴豆酰甘氨酸增高。经静脉滴注葡萄糖和左旋肉碱症状缓解。维持治疗半年后复诊，尿3-羟基3-甲基戊二酸降低，全身情况良好。

Abstract

3-Hydroxy-3-methylglutaric aciduria is a rare disorder of organic acid metabolism caused by 3-hydroxy-3-methylglutaryl-coenzyme A lyase deficiency. The disorder was common in neonatal or infant period. Here a case of late onset 3-hydroxy-3-methylglutaric aciduria complicated by leucodystrophy was reported. The patient was a 7-year-old boy. He presented with progressive headache, drowsiness and vomiting. Hepatic lesions, ketosis and leucopenia were found. Symmetrical diffused leucodystrophy was shown by MRI. Blood levels of isovalerylcarnitine and acetylcarnitine increased significantly. Urinary levels of 3-hydroxy-3-methylglutaric, 3-methylglutaconic, 3-hydroxyglutaric acids and 3-methyl-crotonylglycine increased significantly. Symptoms were released by intravenous infusion of L-carnitine and glucose. After treatment for 6 months, urinary levels of 3-hydroxy-3-methylglutaric aciduria decreased in the boy and his health improved.

导出引用

马艳艳，宋金青，吴桐菲，刘玉鹏，肖江喜，姜玉武，杨艳玲. 迟发型3-羟基-3-甲基戊二酸尿症导致脑白质病[J]. 中国当代儿科杂志. 2011, 13(5): 392-395

MA Yan-Yan, SONG Jin-Qing, WU Tong-Fei, LIU Yu-Peng, XIAO Jiang-Xi, JIANG Yu-Wu, YANG Yan-Ling. Leucodystrophy induced by late onset 3-hydroxy-3-methylglutaric aciduria[J]. Chinese Journal of Contemporary Pediatrics. 2011, 13(5): 392-395

中图分类号： R596

参考文献

［1］Sweetman L. Newborn screening by tandem mass spectrometry: gaining experience［J］. Clin Chem, 2001, 47 (11): 1937-1938.

［2］Faull KF, Bolton PD, Halpern B, Hammond J, Danks DM. The urinary organic acid profile associated with 3-hydroxy-3-methylglutaric aciduria［J］. Clin Chim Acta, 1976, 73(3): 553-559.

［3］Wysocki SJ, Hahnel R. 3-Hydroxy-3-methylglutaric aciduria: 3-hydroxy-3-methylglutaryl-coenzyme A lyase levels in leucocytes［J］. Clin Chim Acta, 1976, 73(2): 373-375.

［4］Wilson WG, Cass MB, Sovik O, Gibson KM, Sweetman L. A child with acute pancreatitis and recurrent hypoglycemia due to 3-hydroxy-3-methylglutaryl-CoA lyase deficiency［J］. Eur J Pediatr, 1984, 142(4): 289-291.

［5］Ozand PT, Devol EB, Gascon GG. Neurometabolic diseases at a national referral center: five years experience at the King Faisal Specialist Hospital and Research Centre［J］. J Child Neurol, 1992, 7(Suppl): S4-S11.

［6］Gibson KM, Cassidy SB, Seaver LH, Wanders RJ, Kennaway NG, Mitchell GA, et al. Fatal cardiomyopathy associated with 3-hydroxy-3-methylglutaryl-CoA lyase deficiency［J］. J Inherit Metab Dis, 1994, 17(3): 291-294.

［7］Wang SP, Robert MF, Gibson KM, Wanders RJ, Mitchell GA. 3-Hydroxy-3-methylglutaryl CoA lyase (HL): mouse and human HL gene (HMGCL) cloning and detection of large gene deletions in two unrelated HL-deficient patients［J］. Genomics, 1996, 33(1): 99-104.

［8］Mitchell GA, Robert MF, Hruz PW, Wang S, Fontaine G, Behnke CE, et al. 3-Hydroxy-3-methylglutaryl coenzyme A lyase (HL). Cloning of human and chicken liver HL cDNAs and characterization of a mutation causing human HL deficiency［J］. J Biol Chem, 1993, 268(6): 4376-4381.

［9］Pie J, Lopez-Vinas E, Puisac B, Menao S, Pie A, Casale C, et al. Molecular genetics of HMG-CoA lyase deficiency［J］. Mol Genet Metab, 2007, 92(3): 198-209.

［10］Zapater N, Pie J, Lloberas J, Rolland MO, Leroux B, Vidailhet M, et al. Two missense point mutations in different alleles in the 3-hydroxy-3-methylglutaryl coenzyme A lyase gene produce 3-hydroxy-3-methylglutaric aciduria in a French patient［J］. Arch Biochem Biophys, 1998, 358(2): 197-203.

［11］Pospisilova E, Mrazova L, Hrda J, Martincova O, Zeman J. Biochemical and molecular analyses in three patients with 3-hydroxy-3-methylglutaric aciduria［J］. J Inherit Metab Dis, 2003, 26(5): 433-441.

［12］Bischof F, Nagele T, Wanders RJ, Trefz FK, Melms A. 3-hydroxy-3-methylglutaryl-CoA lyase deficiency in an adult with leukoencephalopathy［J］. Ann Neurol, 2004, 56(5): 727-730.

［13］罗小平.导致神经系统伤残的遗传代谢缺陷病//左启华.小儿神经系统疾病［M］. 第2版. 北京：人民卫生出版社，2002: 477-478.

［14］Gibson KM, Breuer J, Nyhan WL. 3-Hydroxy-3-methylglutaryl-coenzyme A lyase deficiency: review of 18 reported patients［J］. Eur J Pediatr, 1988, 148(3): 180-186.

［15］Funghini S, Pasquini E, Cappellini M, Donati MA, Morrone A, Fonda C, et al. 3-Hydroxy-3-methylglutaric aciduria in an Italian patient is caused by a new nonsense mutation in the HMGCL gene［J］. Mol Genet Metab, 2001, 73(3): 268-275.

［16］van der Knaap MS, Bakker HD, Valk J. MR imaging and proton spectroscopy in 3-hydroxy-3-methylglutaryl coenzyme A lyase deficiency［J］. AJNR Am J Neuroradiol, 1998, 19(2): 378-382.

［17］Jakobs C, Bojasch M, Duran M, Ketting D, Wadman SK, Leupold D. 3-methyl-3-butenoic acid: an artefact in the urinary metabolic pattern of patients with 3-hydroxy-3-methylglutaryl-CoA lyase deficiency［J］. Clin Chim Acta, 1980, 106(1): 85-89.

［18］杨艳玲. 遗传代谢病的诊断与治疗［J］. 国外医学·内分泌学分册, 2005, 25(4): 238-240.

［19］Dasouki M, Buchanan D, Mercer N, Gibson KM, Thoene J. 3-Hydroxy-3-methylglutaric aciduria: response to carnitine therapy and fat and leucine restriction［J］. J Inherit Metab Dis, 1987, 10 (2): 142-146.

［20］Roe CR, Millington DS, Maltby DA. Identification of 3-methylglutarylcarnitine. A new diagnostic metabolite of 3-hydroxy-3-methylglutaryl-coenzyme A lyase deficiency［J］. J Clin Invest, 1986, 77 (4): 1391-1394.